Mardani Saeed, Nasri Parto, Tavakoli Maryam
Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
J Nephropharmacol. 2013 Jul 1;2(2):27-30. eCollection 2013.
Contrast induced nephropathy is one cause of acute renal failure. Contrast induced nephropathy is the third most common cause of hospital-acquired acute renal failure. The incidence of contrast induced nephropathy in the general population is 0.6% to 2.3%, but when focusing on specific high-risk patients the incidence can increase to more than 40%. Studies suggest that intravenous hydration is the most effective strategy to prevent contrast induced nephropathy. Hydration is inexpensive and is usually risk-free. Administration of optimal fluids before and after the contrast procedure allows for increased urine output and improved outcomes.
对比剂肾病是急性肾衰竭的一个病因。对比剂肾病是医院获得性急性肾衰竭的第三大常见病因。普通人群中对比剂肾病的发病率为0.6%至2.3%，但聚焦于特定高危患者时，发病率可增至40%以上。研究表明，静脉补液是预防对比剂肾病最有效的策略。补液成本低且通常无风险。在进行对比剂检查之前和之后给予最佳液体可增加尿量并改善预后。
